[go: up one dir, main page]

FI935878A0 - Porfycenfoereningar foer fotodynamisk terapi - Google Patents

Porfycenfoereningar foer fotodynamisk terapi

Info

Publication number
FI935878A0
FI935878A0 FI935878A FI935878A FI935878A0 FI 935878 A0 FI935878 A0 FI 935878A0 FI 935878 A FI935878 A FI 935878A FI 935878 A FI935878 A FI 935878A FI 935878 A0 FI935878 A0 FI 935878A0
Authority
FI
Finland
Prior art keywords
photodynamic therapy
porfycenfoereningar
foer
nhr2
aryl
Prior art date
Application number
FI935878A
Other languages
English (en)
Finnish (fi)
Other versions
FI935878A7 (fi
FI935878L (fi
Inventor
Emanuel Vogel
Thomas Benninghaus
Clemens Richert
Martin Muller
Alexander Dennis Cross
Original Assignee
Cytopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytopharm Inc filed Critical Cytopharm Inc
Publication of FI935878A7 publication Critical patent/FI935878A7/fi
Publication of FI935878L publication Critical patent/FI935878L/fi
Publication of FI935878A0 publication Critical patent/FI935878A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI935878A 1991-06-28 1992-06-05 Porfycenfoereningar foer fotodynamisk terapi FI935878A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/723,394 US5179120A (en) 1991-06-28 1991-06-28 Porphycene compounds for photodynamic therapy
PCT/US1992/004624 WO1993000087A1 (en) 1991-06-28 1992-06-05 Porphycene compounds for photodynamic therapy

Publications (3)

Publication Number Publication Date
FI935878A7 FI935878A7 (fi) 1993-12-27
FI935878L FI935878L (fi) 1993-12-27
FI935878A0 true FI935878A0 (fi) 1993-12-27

Family

ID=24906063

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935878A FI935878A0 (fi) 1991-06-28 1992-06-05 Porfycenfoereningar foer fotodynamisk terapi

Country Status (11)

Country Link
US (1) US5179120A (no)
EP (1) EP0591355B1 (no)
JP (1) JP3184218B2 (no)
AT (1) ATE190309T1 (no)
AU (1) AU664377B2 (no)
CA (1) CA2111323A1 (no)
DE (1) DE69230755T2 (no)
ES (1) ES2146213T3 (no)
FI (1) FI935878A0 (no)
NO (1) NO301981B1 (no)
WO (1) WO1993000087A1 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262401A (en) * 1991-06-28 1993-11-16 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
DE59101214D1 (de) * 1991-07-15 1994-04-21 Artesan Pharma Gmbh Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
AU3786093A (en) * 1992-04-30 1993-11-29 American Cyanamid Company High-power light-emitting diodes for photodynamic therapy
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
DE4311627B4 (de) * 1993-04-08 2005-08-25 Robert Bosch Gmbh Kraftstoffeinspritzeinrichtung für Brennkraftmaschinen
JPH0753381A (ja) * 1993-07-09 1995-02-28 Ciba Geigy Ag 局所投与可能な亜鉛フタロシアニン組成物
US5489279A (en) * 1994-03-21 1996-02-06 Dusa Pharmaceuticals, Inc. Method of applying photodynamic therapy to dermal lesion
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5637608A (en) * 1995-04-06 1997-06-10 Cytopharm, Inc. 9-substituted porphycenes
US5610175A (en) * 1995-04-06 1997-03-11 Cytopharm, Inc. 9-Substituted porphycenes
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
JP2012092145A (ja) * 1996-03-11 2012-05-17 Qlt Inc 眼の光力学的治療による視力改善用組成物
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
GB9608484D0 (en) * 1996-04-25 1996-07-03 Glaxo Group Ltd Flourescent lamp photodynamic therapy (PDT) apparatus and method
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
AU4668097A (en) * 1996-10-09 1998-05-05 Alexander D. Cross 9-substituted porphycenes
CA2271717A1 (en) 1996-12-12 1998-06-18 Prolume, Ltd. Apparatus and method for detecting and identifying infectious agents
US5756724A (en) * 1997-04-22 1998-05-26 Cytopharm, Inc. High-yielding ullmann reaction for the preparation of bipyrroles
US6107326A (en) * 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
US6627288B1 (en) * 2000-08-10 2003-09-30 Mitsui Chemicals, Inc. Optical recording medium and porphycene compound
CZ303792B6 (cs) 2000-11-29 2013-05-09 Pci Biotech As Zpusob zavedení molekuly do bunky
AU2002220853B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
WO2003072581A1 (en) 2002-02-26 2003-09-04 Board Of Regents, The University Of Texas System Cyclo[n]pyrroles and methods thereto
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
CA2485224A1 (en) * 2002-05-08 2003-11-20 Yeda Research And Development Co. Ltd. Sensitized online bold-mri imaging method
ES2197818B1 (es) * 2002-06-11 2005-02-01 Institut Quimic De Sarria Cets 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US8703050B2 (en) * 2009-03-16 2014-04-22 Ondine International Ltd. Composition for photodynamic disinfection
JP2012520876A (ja) * 2009-03-16 2012-09-10 オンディーヌ インターナショナル リミテッド 光線力学殺菌用の組成物
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
ES2372854B1 (es) * 2010-07-02 2012-12-03 Institut Quimic De Sarria Cets, Fundacio Privada Derivados catiónicos de 2, 7, 12, 17-arilporficenos. procedimiento de preparación y uso como fotosensibilizadores en terapia fotodinámica antimicrobiana.
KR101933620B1 (ko) * 2012-09-18 2018-12-28 삼성전자주식회사 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법
WO2015183346A2 (en) 2014-01-31 2015-12-03 Washington University Imaging and treatment of pathophysiologic conditions by cerenkov radiation
US9974870B2 (en) 2014-06-09 2018-05-22 Washington University Compositions and methods for treatment and imaging using nanoparticles
CN104522058A (zh) * 2014-12-18 2015-04-22 安徽大学 一种含有藻胆蛋白的光敏杀菌剂及其制备方法及其杀菌的用途
EP4458804A1 (de) 2023-05-04 2024-11-06 TriOptoTec GmbH Verfahren zur herstellung eines gegenstandes, phenalen-1-on-verbindung sowie deren verwendung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3989815A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Novel N-bis-azacyclopentan-2-onyl alkanes
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
EP0220686B1 (en) * 1985-10-23 1992-12-30 Nihon Medi-Physics Co., Ltd. Porphyrin derivatives, and their production and use
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5124449A (en) * 1990-09-20 1992-06-23 Basf Aktiengesellschaft Azaporphyrin derivatives
AU2956992A (en) * 1991-12-17 1993-07-19 Cheil Foods & Chemicals, Inc. Novel 10-hydroxy pheophytin (a)
TW235298B (no) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
FI935878A7 (fi) 1993-12-27
AU664377B2 (en) 1995-11-16
NO934837D0 (no) 1993-12-27
EP0591355B1 (en) 2000-03-08
JP3184218B2 (ja) 2001-07-09
DE69230755T2 (de) 2000-11-02
ES2146213T3 (es) 2000-08-01
US5179120A (en) 1993-01-12
DE69230755D1 (de) 2000-04-13
AU2187092A (en) 1993-01-25
EP0591355A1 (en) 1994-04-13
CA2111323A1 (en) 1993-01-07
FI935878L (fi) 1993-12-27
NO934837L (no) 1994-02-24
ATE190309T1 (de) 2000-03-15
EP0591355A4 (en) 1995-01-18
NO301981B1 (no) 1998-01-05
JPH06508834A (ja) 1994-10-06
WO1993000087A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
FI935878A0 (fi) Porfycenfoereningar foer fotodynamisk terapi
JPS5557572A (en) Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it
NO861722L (no) Fremgangsmaate for fremstilling av tetrapyrrol-polyaminomonocarboxylsyrederivater.
ATE83924T1 (de) Ibuprofen-cyclodextrin-einschlusskomplexe enthaltende pharmazeutische zubereitungen.
ITMI931324A1 (it) Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
EP0543015A4 (en) Composition, method and kit for potentiating antitumor activity and for curing tumor
FI102964B1 (fi) Terapeuttisia yhdisteitä
EP0210351A3 (en) Use of porphyrin derivatives in the detection and treatment of tumours
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
DE69426244D1 (de) Einen für Tumore cytotoxischen Faktor enthaltende pharmazeutische Zusammensetzung
DE3770788D1 (de) Derivate von n-(methylsulfonylphenylaethyl)-2-propenamiden, und deren verwendung als antibiotika.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
RU93057732A (ru) N-//4,5-диокси- и 4,5,8-тригидрокси-9,10-дигидро-9,10-диоксо-2-антраценил(карбонил)-аминокислот, полезные для лечения костносуставных заболеваний
FI870811A7 (fi) Pentapeptider med en cellvaextreglerande effekt och ett foerfarande foer framstaellning av desamma.
DE69233315D1 (de) Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung
ATE175977T1 (de) Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen
ES2065242A1 (es) Derivados del acido fenilacetico, procedimiento para su obtencion y utilizacion correspondiente.
RU93058640A (ru) Производные порфицена, фармацевтическая композиция и способ фотодинамической терапии
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
FI860105L (fi) Medel foer hoejande ph-vaerdet i tandplack och foerfarande foer framstaellning daerav.
KR970704682A (ko) 테크네튬-술폰아미드 착물, 이들의 용도, 이들을 함유하는 약제, 및 상기 착물 및 약제의 제조 방법(Technetium-Sulphonamide Complexes, Their Use, Pharmaceutical Agents Containing Them, and Process for Producing the Complexes and Agents)
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
IT8019353A0 (it) Sali di aminoacidi basici adattivita' terapeutica, procedimento per la preparazione e relative composizioni farmaceutiche.
RU94026088A (ru) Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли

Legal Events

Date Code Title Description
FD Application lapsed